179 related articles for article (PubMed ID: 11023663)
1. Soluble CD40 ligand induces beta-chemokine production by macrophages and resistance to HIV-1 entry.
di Marzio P; Mariani R; Lui R; Thomas EK; Landau NR
Cytokine; 2000 Oct; 12(10):1489-95. PubMed ID: 11023663
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of CD40 ligand/trimer stimulation on the ability of dendritic cells to replicate and transmit HIV infection: evidence for CC-chemokine-dependent and -independent mechanisms.
McDyer JF; Dybul M; Goletz TJ; Kinter AL; Thomas EK; Berzofsky JA; Fauci AS; Seder RA
J Immunol; 1999 Mar; 162(6):3711-7. PubMed ID: 10092834
[TBL] [Abstract][Full Text] [Related]
3. Is decreased HIV-1 infectivity of placental macrophages caused by high levels of beta-chemokines?
Meléndez J; García V; Sánchez E; Delgado R; Torres G; Meléndez-Guerrero LM
Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL51-9. PubMed ID: 11936874
[TBL] [Abstract][Full Text] [Related]
4. Regulation of human immunodeficiency virus type 1 infection, beta-chemokine production, and CCR5 expression in CD40L-stimulated macrophages: immune control of viral entry.
Cotter RL; Zheng J; Che M; Niemann D; Liu Y; He J; Thomas E; Gendelman HE
J Virol; 2001 May; 75(9):4308-20. PubMed ID: 11287580
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of CCR5 expression by IL-12 through induction of beta-chemokines in human T lymphocytes.
Wang J; Guan E; Roderiquez G; Norcross MA
J Immunol; 1999 Dec; 163(11):5763-9. PubMed ID: 10570258
[TBL] [Abstract][Full Text] [Related]
6. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
[TBL] [Abstract][Full Text] [Related]
7. Effect of beta-chemokines on human immunodeficiency virus type 1 replication, binding, uncoating, and CCR5 receptor expression in human monocyte-derived macrophages.
Jiang Y; Jolly PE
J Hum Virol; 1999; 2(3):123-32. PubMed ID: 10413363
[TBL] [Abstract][Full Text] [Related]
8. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines.
Margolis LB; Glushakova S; Grivel JC; Murphy PM
J Clin Invest; 1998 May; 101(9):1876-80. PubMed ID: 9576751
[TBL] [Abstract][Full Text] [Related]
9. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.
Oliva A; Kinter AL; Vaccarezza M; Rubbert A; Catanzaro A; Moir S; Monaco J; Ehler L; Mizell S; Jackson R; Li Y; Romano JW; Fauci AS
J Clin Invest; 1998 Jul; 102(1):223-31. PubMed ID: 9649576
[TBL] [Abstract][Full Text] [Related]
11. Increased CD4 and CCR5 expression and human immunodeficiency virus type 1 entry in CD40 ligand-stimulated macrophages.
Bergamini A; Bolacchi F; Pesce CD; Carbone M; Cepparulo M; Demin F; Rocchi G
J Infect Dis; 2002 Jun; 185(11):1567-77. PubMed ID: 12023762
[TBL] [Abstract][Full Text] [Related]
12. The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.
Aquaro S; Menten P; Struyf S; Proost P; Van Damme J; De Clercq E; Schols D
J Virol; 2001 May; 75(9):4402-6. PubMed ID: 11287590
[TBL] [Abstract][Full Text] [Related]
13. Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5.
Cordelier P; Kulkowsky JW; Ko C; Matskevitch AA; McKee HJ; Rossi JJ; Bouhamdan M; Pomerantz RJ; Kari G; Strayer DS
Gene Ther; 2004 Nov; 11(22):1627-37. PubMed ID: 15295615
[TBL] [Abstract][Full Text] [Related]
14. Soluble glycosaminoglycans Do not potentiate RANTES antiviral activity on the infection of primary macrophages by human immunodeficiency virus type 1.
Ylisastigui L; Bakri Y; Amzazi S; Gluckman JC; Benjouad A
Virology; 2000 Dec; 278(2):412-22. PubMed ID: 11118364
[TBL] [Abstract][Full Text] [Related]
15. Activation of beta-chemokines and CCR5 in persons infected with human immunodeficiency virus type 1 and tuberculosis.
Mayanja-Kizza H; Wajja A; Wu M; Peters P; Nalugwa G; Mubiru F; Aung H; Vanham G; Hirsch C; Whalen C; Ellner J; Toossi Z
J Infect Dis; 2001 Jun; 183(12):1801-4. PubMed ID: 11372034
[TBL] [Abstract][Full Text] [Related]
16. Beta-chemokines that inhibit HIV-1 infection of human macrophages stimulate uptake and promote destruction of Trypanosoma cruzi by human macrophages.
Lima MF; Zhang Y; Villalta F
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1067-76. PubMed ID: 9449540
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of macrophage inflammatory protein-1alpha, macrophage inflammatory protein-1beta, and RANTES by Candida albicans and Cryptococcus neoformans in peripheral blood mononuclear cells from persons with and without human immunodeficiency virus infection.
Huang C; Levitz SM
J Infect Dis; 2000 Feb; 181(2):791-4. PubMed ID: 10669379
[TBL] [Abstract][Full Text] [Related]
18. GM-CSF and M-CSF modulate beta-chemokine and HIV-1 expression in microglia.
Si Q; Cosenza M; Zhao ML; Goldstein H; Lee SC
Glia; 2002 Aug; 39(2):174-83. PubMed ID: 12112368
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
Elliott MB; Tebbey PW; Pryharski KS; Scheuer CA; Laughlin TS; Hancock GE
J Med Virol; 2004 Jun; 73(2):300-8. PubMed ID: 15122808
[TBL] [Abstract][Full Text] [Related]
20. TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression.
Lane BR; Markovitz DM; Woodford NL; Rochford R; Strieter RM; Coffey MJ
J Immunol; 1999 Oct; 163(7):3653-61. PubMed ID: 10490959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
